Breaking News
Investing Pro 0
Cyber Monday Extended SALE: Up to 60% OFF InvestingPro+ CLAIM OFFER

Advent to test choppy buyout market with sale of France's IDEMIA -sources

Economy Sep 01, 2022 18:11
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters.

By Julien Ponthus, Mathieu Rosemain and Emma-Victoria Farr

PARIS/FRANKFURT (Reuters) - Private equity group Advent is set to launch the sale of French biometrics and fingerprint identification firm IDEMIA, sources familiar with the matter said, in a multi-billion euro deal that will test a choppy buyout market this autumn.

Goldman Sachs (NYSE:GS) and Rothschild have been mandated by Advent and are expected to launch the sale imminently, sources close to the deal said. The two banks, IDEMIA and Advent all declined to comment.

The timing of what would be one of the biggest private equity deals of the year in France is not ideal from a seller's point of view.

Wall Street's Nasdaq has lost about 25% year-to-date and the European tech index has plunged over 30%.

The valuation of tech companies typically suffers when interest rates rise, as they cut the appeal of the distant cash flows of fast-growing companies versus safer government bonds.

Sources said it was hard to value IDEMIA as a whole as some bidders would likely only submit offers for its prized biometrics and ID business and could make a pass on the unit providing sim cards and payments platforms.

Sources have mentioned a rough value of 3 billion euros ($2.98 billion) for the biometrics and ID business and about one billion for the sim card operations, but precise valuations will not be drafted until the company's data is accessible.

The tightening of monetary policies and a slowing economy have created a tougher environment for debt syndication, hindering the ability of buyers to raise debt and compete in auctions.

Major U.S. and European banks wrote down hundreds of millions of dollars on leveraged loans in the second quarter and the bill is expected to rise.

IDEMIA, which has been majority owned by Advent since 2017 and also counts state-owned investment bank Bpifrance as a shareholder, provides facial recognition and identification products for border control, working with government agencies to verify travellers' identity.

Because of the sensitivity of these activities, a successful bidder will need to get government clearance.

"There's a mix of French and U.S. authorities aiming to protect their respective proprietary technologies (...) it won't be an easy deal for any industrial group," a source close to IDEMIA said.

French President Emmanuel Macron's pro-business government, which otherwise seeks to attract international investors, has strengthened its oversight over foreign investments.

The fact that IDEMIA has an international client base and is already owned by a non-French entity suggests the French government would not necessarily insist on finding a national acquirer, sources said.

($1 = 1.0060 euros)

Advent to test choppy buyout market with sale of France's IDEMIA -sources
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email